HIGHFDA DRUG

Amneal Chlorpromazine Hydrochloride 25 mg 100-count Recalled in 2025 for Packaging Contamination

Amneal Pharmaceuticals LLC is recalling 7,228 bottles of CHLORPROMAZINE HYDROCHLORIDE tablets sold nationwide in the United States. Packaging coils used in the bottles tested positive for a microorganism, though no tablets were contaminated. Stop using this product immediately and contact Amneal or your healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 18, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 18, 2025
Hazard Level
HIGH
Brands
Chlorpromazine Hydrochloride, Amneal Pharmaceuticals
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Chlorpromazine Hydrochloride, Amneal Pharmaceuticals
Product type
Chlorpromazine Hydrochloride Tablets 25 mg, 100-count bottles (Rx Only)
Model numbers
AM240617, AM240618
UPC codes
69238-1054, 69238-1056, 69238-1058, 69238-1060, 69238-1062, 69238-1054-1, 69238-1056-1, 69238-1058-1 +2 more
Sizes
100-count bottles
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 18, 2025

  2. Reported by FDA DRUG

    September 10, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used to treat certain psychiatric conditions. It is sold as prescription-only medication.

Why This Is Dangerous

A manufacturing packaging coil contained a microorganism. The tablets themselves were not contaminated, but the packaging defect raises contamination risk.

Industry Context

This recall is not indicated as part of a broader industry pattern.

Real-World Impact

Patients with affected lots should stop using the product and await guidance. The recall covers 7,228 bottles distributed nationwide in the U.S.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 69238-1056-1 on the bottle.
  2. Check Lot AM240617 or AM240618.
  3. Verify Expiration Date 04/30/2027.

Where to find product info

NDC 69238-1056-1; Lot AM240617; Lot AM240618; Exp 04/30/2027; Manufactured in India; Distributed by Amneal Pharmaceuticals LLC, NJ.

What timeline to expect

Refunds/replacements expected in 4-6 weeks after eligibility is confirmed.

If the manufacturer is unresponsive

  • Document all communications with Amneal.
  • If Amneal is unresponsive, contact the FDA or your pharmacist for guidance.

How to prevent similar issues

  • Only obtain prescription medications from licensed pharmacies.
  • Monitor recall updates from Amneal and FDA.
  • Discuss alternatives with your healthcare provider if needed.

Documentation advice

Keep recall letter, bottle labels, lot numbers, and any correspondence with Amneal for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDC 69238-1056-1. Lot AM240617 and Lot AM240618. Expiration date 04/30/2027. Quantity recalled: 7,228 bottles of 100-count each. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. Sold nationwide in the U.S. Rx Only. Category: Health & Personal Care; Drugs & Medications.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Lot AM240617 and Lot AM240618 affected
  • Packaging coil contamination detected
  • Tablets not contaminated

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeChlorpromazine Hydrochloride Tablets 25 mg, 100-count bottles (Rx Only)
Sold At
Multiple Retailers

Product Details

Model Numbers
AM240617
AM240618
UPC Codes
69238-1054
69238-1056
69238-1058
+7 more
Affected States
ALL
Report Date
September 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls